➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKinsey
Harvard Business School
Johnson and Johnson
Medtronic
Moodys
Boehringer Ingelheim

Last Updated: June 5, 2020

DrugPatentWatch Database Preview

ALBUTEROL SULFATE Drug Profile


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Which patents cover Albuterol Sulfate, and when can generic versions of Albuterol Sulfate launch?

Albuterol Sulfate is a drug marketed by Cipla, Perrigo Pharms Co, Actavis Mid Atlantic, Apotex Inc, Aurobindo Pharma Ltd, Bausch And Lomb, Copley Pharm, Hi Tech Pharma, Landela Pharm, Mylan Speclt, Nephron, Ritedose Corp, Roxane, Sun Pharm, Teva Pharms, Watson Labs, Watson Labs Inc, Wockhardt Eu Operatn, Amneal Pharms, Cosette, Lannett Co Inc, Mova, Quagen, Teva, Vistapharm, Mylan, Am Therap, Amneal Pharms Co, Appco, Arise, Dava Pharms Inc, Pliva, Sun Pharm Industries, Ucb Inc, Virtus Pharm, Warner Chilcott, Yaopharma Co Ltd, Fosun Pharma, and Watson Labs Teva. and is included in seventy-four NDAs.

The generic ingredient in ALBUTEROL SULFATE is albuterol sulfate; ipratropium bromide. There are thirty-eight drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the albuterol sulfate; ipratropium bromide profile page.

Paragraph IV (Patent) Challenges for ALBUTEROL SULFATE
Tradename Dosage Ingredient NDA Submissiondate
PROVENTIL-HFA AEROSOL, METERED;INHALATION albuterol sulfate 020503 2015-05-20
PROAIR HFA AEROSOL, METERED;INHALATION albuterol sulfate 021457 2012-05-18
ACCUNEB SOLUTION;INHALATION albuterol sulfate 020949 2005-10-19
VOLMAX TABLET, EXTENDED RELEASE;ORAL albuterol sulfate 019604
VENTOLIN SYRUP;ORAL albuterol sulfate 019621

US Patents and Regulatory Information for ALBUTEROL SULFATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Warner Chilcott ALBUTEROL SULFATE albuterol sulfate TABLET;ORAL 072818-001 Jan 9, 1990 DISCN No No   Start Trial   Start Trial   Start Trial
Mylan ALBUTEROL SULFATE albuterol sulfate TABLET, EXTENDED RELEASE;ORAL 078092-002 Jan 29, 2007 AB RX No No   Start Trial   Start Trial   Start Trial
Amneal Pharms ALBUTEROL SULFATE albuterol sulfate SYRUP;ORAL 079241-001 May 12, 2010 AA RX No No   Start Trial   Start Trial   Start Trial
Watson Labs Teva ALBUTEROL SULFATE AND IPRATROPIUM BROMIDE albuterol sulfate; ipratropium bromide SOLUTION;INHALATION 077063-001 Dec 31, 2007 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Harvard Business School
Johnson and Johnson
Medtronic
Moodys
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.